Repligen (NASDAQ:RGEN) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Repligen (RGEN) operate in?

Repligen is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

Repligen Stock (NASDAQ: RGEN) stock price, news, charts, stock research, profile.

Open	$164.34
Close	$158.99
Volume / Avg.	795.36K / 553.50K
Day Range	$156.18 - $165.00
52 Wk Range	113.50 - 207.87
Market Cap	$8.91B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	6.9%
Days to Cover	5.12

Recent News

Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook

Repligen reported Q4 EPS of $0.44, beating estimates, with revenue of $167.55 million. The company projects 2025 sales of up to $710 million as the market recovers.

Vandana Singh

Repligen Q3 Earnings Beat Expectations, Highlights Improving Market Conditions, Analyst Says Well-Positioned For Long-Term Growth

Repligen Q3 earnings beat expectations with $0.43 EPS and $154.87 million in sales. The company raises 2024 EPS guidance and reports strong growth in CDMO and equipment.

Vandana Singh

Wall Street Gains Ground As Consumer Sentiment Improves; Gold Hits Record Highs, Boosting Mining Stocks: What's Driving Markets Friday?

Wall Street edged slightly higher on Friday, with major equity indices showing modest gains at midday in New York.

Piero Cingari

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$164.34
Close	$158.99
Volume / Avg.	795.36K / 553.50K
Day Range	$156.18 - $165.00
52 Wk Range	113.50 - 207.87
Market Cap	$8.91B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	6.9%
Days to Cover	5.12

About Repligen Corp.

Sector

Health Care

Industry

Life Sciences Tools & Services

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops a...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Repligen (RGEN) stock?

You can purchase shares of Repligen (NASDAQ:RGEN) through any online brokerage.

View our list of the best stock brokerages

Who are Repligen (RGEN) competitors?

Other companies in Repligen’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), BioLife Solns (NASDAQ:BLFS) and Waters (NYSE:WAT).

What is the forecast, or price target, for Repligen (RGEN) stock?

Repligen has a consensus price target of $189.00.

What is the current price for Repligen (RGEN)?

The stock price for Repligen (NASDAQ: RGEN) is $158.99 last updated February 21, 2025 at 4:37 PM EST.

Does Repligen (RGEN) pay a dividend?

There are no upcoming dividends for Repligen.

When is Repligen (NASDAQ:RGEN) reporting earnings?

Repligen’s Q1 earnings are confirmed for Wednesday, April 30, 2025.

Is Repligen (RGEN) going to split?

There is no upcoming split for Repligen.

What sector and industry does Repligen (RGEN) operate in?

Repligen is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

Comments

Repligen

Repligen (RGEN) Forecast